Showing results (81-90 of 3,013) with videos related to
Sort By:
Pageof 302
Cardiovascular Drugs and Therapy|January 28, 2022
Flavopiridol Mitigates the Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Targeting Cyclin-Dependent Kinase 9Qi Jia, Zhiqiang Hu, Nannan Song, et al.Cardiovascular Drugs and Therapy|January 31, 2022
Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic UpdatePedro Vaz-Salvador, Rui Adão, Inês Vasconcelos, et al.Cardiovascular Drugs and Therapy|October 27, 2021
Model-Based Risk Prediction of Rivaroxaban with Amiodarone for Moderate Renal Impaired Elderly PopulationZiteng Wang, Eleanor Jing Yi Cheong, Pipin Kojodjojo, et al.Cardiovascular Drugs and Therapy|October 15, 2021
Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and SafetySumon Roy, Robert A Kloner, Fadi N Salloum, et al.Cardiovascular Drugs and Therapy|September 21, 2021
Treatment and Prophylaxis of Post-pericardiotomy Syndrome in Cardiac Surgery Patients: a Systematic ReviewOmar Giacinto, Alessandro Minati, Mario Lusini, et al.Cardiovascular Drugs and Therapy|December 2, 2000
Atrial natriuretic peptide reduces the severe consequences of coronary artery occlusion in anaesthetized dogsM A Rastegar, A Végh, J G Papp, et al.Cardiovascular Drugs and Therapy|December 2, 2000
Isosorbide-2-mononitrate reduces the consequences of myocardial ischaemia, including arrhythmia severity: implications for preconditioningK György, A Végh, M A Rastegar, et al.Cardiovascular Drugs and Therapy|December 2, 2000
The effect of mibefradil on ischemic episodes with and without increase in heart rateD Tzivoni, Z Gilula, M W Klutstein, et al.Cardiovascular Drugs and Therapy|December 2, 2000
Hemodynamic, antiischemic, and neurohumoral effects of tedisamil and atenolol in patients with coronary artery diseaseV Mitrovic, A Miskovic, M Strau, et al.Cardiovascular Drugs and Therapy|October 12, 1999
Apoptosis in cardiac diseases--new opportunities for novel therapeutics for heart diseasesG Z FeuersteinPageof 302